Your browser doesn't support javascript.
loading
Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.
Trinh, Vincent Q-H; Shi, Chanjuan; Ma, Changqing.
Affiliation
  • Trinh VQ; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Shi C; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Ma C; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
Histopathology ; 77(6): 865-876, 2020 Dec.
Article in En | MEDLINE | ID: mdl-32702178
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Stomach Neoplasms / Neuroendocrine Tumors / Proton Pump Inhibitors / Intestinal Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Histopathology Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Stomach Neoplasms / Neuroendocrine Tumors / Proton Pump Inhibitors / Intestinal Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Histopathology Year: 2020 Document type: Article Affiliation country: Country of publication: